Last reviewed · How we verify
Seizures associated with CDKL5 deficiency disorders
Approved treatments
- Ztalmy · Marinus
Ztalmy works by enhancing the activity of the GABA A receptor, a key player in regulating the activity of neurons in the brain.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Seizures associated with CDKL5 deficiency disorders patent landscape — cliff calendar, originator estates, attackable patents
- Seizures associated with CDKL5 deficiency disorders treatment landscape brief
- Seizures associated with CDKL5 deficiency disorders treatment updates RSS
Frequently asked questions about Seizures associated with CDKL5 deficiency disorders
What drugs treat Seizures associated with CDKL5 deficiency disorders?
Tracked treatments include Ztalmy.
What is the treatment for Seizures associated with CDKL5 deficiency disorders?
Standard treatment for Seizures associated with CDKL5 deficiency disorders includes Ztalmy. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Seizures associated with CDKL5 deficiency disorders patent cliff · Seizures associated with CDKL5 deficiency disorders CI report
- Treatment: Ztalmy · Marinus
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing